A commitment to global collaboration, welcoming international participation and advancing science for the benefit of patients

Pantep Angchaisuksiri; Wolfram Ruf; Jeffrey Weitz; Sam Schulman; Guy A. Young; Bianca Rocca; Emma C. Hansson; Milan Milojevic; Anders Jeppsson

doi:10.4081/btvb.2025.188

Search

Search articles for

Advanced filters

Published AfterYearMonthDay

Published BeforeYearMonthDay

By Author

By Section

Search Results

##search.searchResults.foundPlural##

Tailored therapy with turoctocog alfa pegol according to patient’s lifestyle and hemorrhagic phenotype: from clinical trial to real-life

Ilaria Nichele, Giuseppe Carli, Alberto Tosetto

22-04-2024

https://doi.org/10.4081/btvb.2024.104

408

PDF: 131
The evolving landscape of gene therapy for congenital severe hemophilia: a 2024 state of the art

Giovanni Di Minno, Gaia Spadarella, Ilenia Lorenza Calcaterra, Giancarlo Castaman, Paolo Simioni, Raimondo De Cristofaro, Cristina Santoro, Flora Peyvandi, Matteo Di Minno

04-09-2024

https://doi.org/10.4081/btvb.2024.144

857

PDF: 197

SUPPLEMENTARY MATERIAL: 92
Palestinian patients associations appeal on World Hemophilia Day

Sara Mellano

17-04-2024

https://doi.org/10.4081/btvb.2024.136

325

PDF: 94
Gene transfer in hemophilia A: not cogent yet

Pier Mannuccio Mannucci

20-04-2022

https://doi.org/10.4081/btvb.2022.32

2026

PDF: 231
Growing weapons to fight hemophilia

Pier Mannuccio Mannucci

23-02-2023

https://doi.org/10.4081/btvb.2023.64

752

PDF: 307
Safety of COVID-19 mRNA vaccination in patients with history of acquired hemophilia A: a case series

Luca Puccetti, Vincenzo Sammartano, Federico Caroni, Margherita Malchiodi, Paola Calzoni, Eleonora Franceschini, Lucrezia Galasso, Monica Bocchia

17-10-2022

https://doi.org/10.4081/btvb.2022.40

2385

PDF: 223
The changing landscape of treatment for acquired hemophilia A

Massimo Franchini, Daniele Focosi

30-01-2025

https://doi.org/10.4081/btvb.2025.157

778

PDF: 254
Is non-alcoholic fatty liver disease a prothrombotic risk factor?

Niccolò Bitto, Vincenzo La Mura, Anna Ludovica Fracanzani, Armando Tripodi

19-05-2023

https://doi.org/10.4081/btvb.2023.81

594

PDF: 190
Gene transfer in hemophilia B: a big step forward

Giancarlo Castaman

17-05-2023

https://doi.org/10.4081/btvb.2023.70

866

PDF: 260
An ecological alliance against air pollution and cardiovascular disease

Pier Mannuccio Mannucci

22-03-2022

https://doi.org/10.4081/btvb.2022.21

1733

PDF: 279
Rationale and design of a study on D-dimer use to stratify patients after a first unprovoked venous thromboembolism for their risk of recurrence: extended low-dose Apixaban given only to patients with positive D-dimer results The Apidulcis study

Gualtiero Palareti, Paolo Prandoni, Cristina Legnani, Emilia Antonucci, Serena Zorzi, Alberto Tosetto, Lorenza Bertù, Sophie Testa, Vittorio Pengo, Walter Ageno, Ida Martinelli, Benilde Cosmi, Eugenio Bucherini, Daniela Poli

22-03-2022

https://doi.org/10.4081/btvb.2022.10

1044

PDF: 330

APPENDIX: 67
Diagnosis and management of abnormal uterine bleeding in adolescence An expert Consensus Statement of SIGO (Italian Society of Gynecology and Obstetrics) and SISET (Italian Society for the Study of Hemostasis and Thrombosis)

Roberto Mario Santi, Annamaria Fulghesu, Ezio Zanon, Erica De Candia, Elvira Grandone, Giancarlo Di Renzo, Claudia Succu, Valentina Tosto, Vincenzina Bruni, Paolo Gresele

08-05-2024

https://doi.org/10.4081/btvb.2024.106

815

PDF: 323
Attitude to clinical research among health professionals affiliated with the Italian Federation of Centers for the Diagnosis of Thrombotic Disorders and the Surveillance of the Antithrombotic Therapies (FCSA)

Daniela Poli, Riccardo Tartaglia, Doris Barcellona , Paolo Bucciarelli , Antonio Ciampa, Elvira Grandone, Giuseppe Malcangi, Giuseppe Rescigno, Vincenzo Toschi, Sophie Testa, Alessandro Squizzato

21-03-2023

https://doi.org/10.4081/btvb.2023.59

541

PDF: 222
Remembering the XXVI SISET Congress and the 50th anniversary of its foundation, 2020

Armando Tripodi

17-01-2025

https://doi.org/10.4081/btvb.2025.171

1020

PDF: 193
Interaction between adenosine diphosphate receptors and protein-kinase C isoforms in platelet adhesion under flow condition

Boris Shenkman, Ivan Budnik, Yulia Einav

16-02-2023

https://doi.org/10.4081/btvb.2023.51

1253

pdf: 214
Influence of emicizumab on protein C-mediated clotting regulation

Federica Mancazzo, Antonia Vitulli, Lavinia Dirienzo, Concetta T. Ammollo, Fabrizio Semeraro, Mario Colucci

25-10-2023

https://doi.org/10.4081/btvb.2023.89

1965

PDF: 224

Supplementary Material: 45
The introduction of the international normalized ratio as a breakthrough event in the history of thrombosis

Armando Tripodi

23-01-2025

https://doi.org/10.4081/btvb.2025.169

635

PDF: 211
Management of anticoagulation in atrial fibrillation patients in Italy: insight from the Atrial Fibrillation-Survey on Anticoagulated Patients Register (AF-START)

Daniela Poli, Walter Ageno, Emilia Antonucci, Salvatore Bradamante, Eugenio Bucherini, Paolo Chiarugi, Antonio Chistolini, Benilde Cosmi, Anna Falanga, Antonio Insana, Domenico Lione, Rosa Maria Lombardi, Giuseppe Malcangi, Rossella Marcucci, Giuliana Martini, Lucilla Masciocco, Carmelo Paparo, Daniele Pastori, Simona Pedrini, Vittorio Pengo, Pasquale Pignatelli, Andrea Toma, Sophie Testa, Gualtiero Palareti

27-06-2023

https://doi.org/10.4081/btvb.2023.84

1230

PDF: 280

Supplementary File: 151

1 - 18 of 18 items

Search

Search Results

Tailored therapy with turoctocog alfa pegol according to patient’s lifestyle and hemorrhagic phenotype: from clinical trial to real-life

The evolving landscape of gene therapy for congenital severe hemophilia: a 2024 state of the art

Palestinian patients associations appeal on World Hemophilia Day

Gene transfer in hemophilia A: not cogent yet

Growing weapons to fight hemophilia

Safety of COVID-19 mRNA vaccination in patients with history of acquired hemophilia A: a case series

The changing landscape of treatment for acquired hemophilia A

Is non-alcoholic fatty liver disease a prothrombotic risk factor?

Gene transfer in hemophilia B: a big step forward

An ecological alliance against air pollution and cardiovascular disease

Rationale and design of a study on D-dimer use to stratify patients after a first unprovoked venous thromboembolism for their risk of recurrence: extended low-dose Apixaban given only to patients with positive D-dimer results The Apidulcis study

Diagnosis and management of abnormal uterine bleeding in adolescence An expert Consensus Statement of SIGO (Italian Society of Gynecology and Obstetrics) and SISET (Italian Society for the Study of Hemostasis and Thrombosis)

Attitude to clinical research among health professionals affiliated with the Italian Federation of Centers for the Diagnosis of Thrombotic Disorders and the Surveillance of the Antithrombotic Therapies (FCSA)

Remembering the XXVI SISET Congress and the 50th anniversary of its foundation, 2020

Interaction between adenosine diphosphate receptors and protein-kinase C isoforms in platelet adhesion under flow condition

Influence of emicizumab on protein C-mediated clotting regulation

The introduction of the international normalized ratio as a breakthrough event in the history of thrombosis

Management of anticoagulation in atrial fibrillation patients in Italy: insight from the Atrial Fibrillation-Survey on Anticoagulated Patients Register (AF-START)

authors

reviewers

Categories

indexing

aice

Keywords